Wi-Fi Fingerprinting for Indoor Positioning

Wireless Fidelity (Wi-Fi) Fingerprinting is a remarkable approach developed by modern science to detect the user’s location efficiently. Today, the Global Positioning System (GPS) is used to keep track of our current location for outdoor positioning. In GPS technology, satellite signals cannot reach indoor environments as they are shielded from obstructions so that indoor environments with a lack of Line of Sight (LoS) do not provide enough satellite signal accuracy. Since indoor environments are very difficult to track, thus, a wide variety of techniques for dealing with them have been suggested. The best way to offer an indoor positioning service with the current technology is Wi-Fi since the most commercial infrastructure is well equipped with Wi-Fi routers. For indoor positioning systems (IPS), Wi-Fi fingerprinting approaches are being extremely popular. In this paper, all the approaches for Wi-Fi fingerprinting have been reviewed for indoor position localization. Related to Wi-Fi fingerprinting, most of the algorithms have been interpreted and the previous works of other researchers have been critically analyzed in this paper to get a clear view of the Wi-Fi fingerprinting process

Wi-Fi Fingerprinting for Indoor Positioning

Wireless Fidelity (Wi-Fi) Fingerprinting is a remarkable approach developed by modern science to detect the user’s location efficiently. Today, the Global Positioning System (GPS) is used to keep track of our current location for outdoor positioning. In GPS technology, satellite signals cannot reach indoor environments as they are shielded from obstructions so that indoor environments with a lack of Line of Sight (LoS) do not provide enough satellite signal accuracy. Since indoor environments are very difficult to track, thus, a wide variety of techniques for dealing with them have been suggested. The best way to offer an indoor positioning service with the current technology is Wi-Fi since the most commercial infrastructure is well equipped with Wi-Fi routers. For indoor positioning systems (IPS), Wi-Fi fingerprinting approaches are being extremely popular. In this paper, all the approaches for Wi-Fi fingerprinting have been reviewed for indoor position localization. Related to Wi-Fi fingerprinting, most of the algorithms have been interpreted and the previous works of other researchers have been critically analyzed in this paper to get a clear view of the Wi-Fi fingerprinting process

Agricultural Production System Based On IOT

Internet of things (IoT) is not a single word, but it has gathered billions of devices in the same lane. The Internet of things has given the lives of things. Machines have a sense now like a human. It works remotely as the program has been settled inside the chip. The system has become so smart and reliable. The Internet of things has brought out changes in most of the sectors of humankind. Meanwhile, agriculture is the main strength of a country. The more the production of agricultural products increased, the world will be more completeness from food shortage. The production of agriculture can be increased when the IoT system can be entirely implemented in the agricultural sector. Most of the approaches for IoT based agriculture have been reviewed in this paper. Related to IoT based agriculture, most of the architecture and methodology have been interpreted and have been critically analyzed based on previous related work of the researchers. This paper will be able to provide a complete idea with the architecture and methodology in the field of IoT based agriculture. Moreover, the challenges for agricultural IoT are discussed with the methods provided by the researche

Security Features in Fingerprint Biometric System

Nowadays, embedded systems run in every setting all around the globe. Recent advances in technology have created many sophisticated applications rich with functionality we have never seen. Nonetheless, security and privacy were a common issue for these systems, whether or not sensitive data can be protected from malicious attacks. These concerns are justified on the grounds that the past of security breaches and the resulting consequences narrate horrific stories concerning embedded systems. The attacks are now evolving, becoming more complex with technological advancements. Therefore, a new way of implementing security in embedded systems must be pursued. This paper attempts to demonstrate the incorporation of security features in fingerprint biometric system in the requirements analysis phase, ensuring the same throughout the system life cycle of embedded systems based on case study. The comparison of various biometric technologies such as face, fingerprint, iris, palm print, hand geometry gait, signature, and keystroke is presented. The aim of this paper includes analyzing, decomposing and transforming the threats and counter-measures identified during the requirements analysis using the abuse case into more specific safety requirements or functions. Furthermore, we have shown that the incorporation of security features into the biometric fingerprint system by analyzing the requirements of the system and providing the main steps for the protection of the biometric system in this paper

Agricultural Production System Based On IOT

Internet of things (IoT) is not a single word, but it has gathered billions of devices in the same lane. The Internet of things has given the lives of things. Machines have a sense now like a human. It works remotely as the program has been settled inside the chip. The system has become so smart and reliable. The Internet of things has brought out changes in most of the sectors of humankind. Meanwhile, agriculture is the main strength of a country. The more the production of agricultural products increased, the world will be more completeness from food shortage. The production of agriculture can be increased when the IoT system can be entirely implemented in the agricultural sector. Most of the approaches for IoT based agriculture have been reviewed in this paper. Related to IoT based agriculture, most of the architecture and methodology have been interpreted and have been critically analyzed based on previous related work of the researchers. This paper will be able to provide a complete idea with the architecture and methodology in the field of IoT based agriculture. Moreover, the challenges for agricultural IoT are discussed with the methods provided by the researche

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

Background: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding. Methods: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124. Findings: Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98). Interpretation: We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial

System for improving sleep quality by using internet of things

Disorders pertaining to the quantification of sleep and sleeping patterns have significantly gained momentum. The result of such disorders in the worst case has led to an alarming rate of fatal deaths. There are numerous causes for sleep deprivation. One of the causes is found to be the environmental condition of the location of sleeping. The lighting, humidity and temperature of the room affects sleep. Using Internet of Things and Artificial Intelligence, the proposed system aims at tracking the sleeping patterns, finding the causes, relating them with environmental parameters, i.e., temperature, humidity and light intensity and then controlling the affecting parameters to optimize the environment for a better quality of sleep

IoT enabled wireless health monitoring system using textile antenna

Health monitoring systems have predominantly been in the limelight in recent years. This progressive field has seen innovative approaches and breathtaking features introduced by means of the Internet of Things (IoT). This paper takes a step forward as an effort to prioritize user's comfort incorporating Wemos D1 Mini and Textile Antenna, ruling out the possibility of forgetting the wearable at home. This essentially introduces how sensors clubbed with a textile antenna could be the new face of IoT in the coming years. The health parameters, including heart rate, pulse rate and body temperature, can conveniently be accessed by the guardian through an application designed exclusively to take immediate action. The project's testing phase delivered coherent results with the textile antenna fixed on the patient's outfit. With the successful deployment, the concerned doctor could receive unhampered notifications about the patient's health condition without further ado

Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

BackgroundTranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding.MethodsWe did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124.FindingsBetween July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98).InterpretationWe found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial.</div